KRNM.F Stock Overview

Provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. More details

KRNM.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Trading at 85.7% below our estimate of its fair value

Earnings are forecast to grow 72.01% per year

Risk Analysis

Shares are highly illiquid

Shareholders have been substantially diluted in the past year

Interest payments are not well covered by earnings

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Clariane SE Competitors

National HealthCare

NYSEAM:NHC

US$1.5b

Ardent Health Partners

NYSE:ARDT

US$1.9b

Brookdale Senior Living

NYSE:BKD

US$1.3b

PACS Group

NYSE:PACS

US$1.6b

Price History & Performance

Summary of share price highs, lows and changes for Clariane
Historical stock prices
Current Share Price	€4.00
52 Week High	€4.05
52 Week Low	€2.16
Beta	0.84
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-88.34%

Recent updates

Shareholder Returns

	KRNM.F	US Healthcare	US Market
7D	0%	-0.4%	2.2%
1Y	n/a	-9.6%	8.2%

Return vs Industry: Insufficient data to determine how KRNM.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how KRNM.F performed against the US Market.

Price Volatility

Is KRNM.F's price volatile compared to industry and market?
KRNM.F volatility
KRNM.F Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.7%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	4.1%

Stable Share Price: KRNM.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine KRNM.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	61,798	Sophie Boissard	www.clariane.com

Clariane SE provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. The company operates long-term care and short stays nursing homes. It also provides diagnosis outpatient programs; healthcare services comprising medical and full hospitalization services, as well as day hospitalisation and consultations; and operates post-acute and rehabilitation care facilities, mental healthcare clinics, hospital home care networks, and home community nursing facilities.

Clariane SE Fundamentals Summary

How do Clariane's earnings and revenue compare to its market cap?
KRNM.F fundamental statistics
Market cap	US$1.55b
Earnings (TTM)	-US$34.33m
Revenue (TTM)	US$5.98b

0.3x

P/S Ratio

-45.1x

P/E Ratio

Is KRNM.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KRNM.F income statement (TTM)
Revenue	€5.28b
Cost of Revenue	€3.59b
Gross Profit	€1.69b
Other Expenses	€1.72b
Earnings	-€30.33m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Jul 29, 2025

Earnings per share (EPS)	-0.085
Gross Margin	31.99%
Net Profit Margin	-0.57%
Debt/Equity Ratio	98.6%

How did KRNM.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/06 16:36
End of Day Share Price	2025/03/06 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Clariane SE is covered by 17 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Fraser Donlon	Berenberg
Laurent Gelebart	BNP Paribas Exane
Bruno de La Rochebrochard	Bryan Garnier & Co